Downregulation of miR-505-3p predicts poor bone metastasis-free survival in prostate cancer | |
Tang, Yubo; Wu, Bowen; Huang, Shuai; Peng, Xinsheng; Li, Xing; Huang, Xiufang; Zhou, Wei; Xie, Peigen*; He, Peiheng* | |
刊名 | Oncology Reports |
2019 | |
卷号 | 41期号:1页码:57-66 |
关键词 | miR-505-3p bone metastasis marker prostate cancer |
ISSN号 | 1021-335X |
DOI | 10.3892/or.2018.6826 |
URL标识 | 查看原文 |
WOS记录号 | WOS:000452152300005;PMID:30365141 |
内容类型 | 期刊论文 |
URI标识 | http://www.corc.org.cn/handle/1471x/3317834 |
专题 | 中南大学 |
作者单位 | [Tang, Yubo] Sun Yat Sen Univ, Affiliated Hosp 1, Dept Pharm, Guangzhou 510080, Guangdong, Peoples R China. |
推荐引用方式 GB/T 7714 | Tang, Yubo,Wu, Bowen,Huang, Shuai,et al. Downregulation of miR-505-3p predicts poor bone metastasis-free survival in prostate cancer[J]. Oncology Reports,2019,41(1):57-66. |
APA | Tang, Yubo.,Wu, Bowen.,Huang, Shuai.,Peng, Xinsheng.,Li, Xing.,...&He, Peiheng*.(2019).Downregulation of miR-505-3p predicts poor bone metastasis-free survival in prostate cancer.Oncology Reports,41(1),57-66. |
MLA | Tang, Yubo,et al."Downregulation of miR-505-3p predicts poor bone metastasis-free survival in prostate cancer".Oncology Reports 41.1(2019):57-66. |
个性服务 |
查看访问统计 |
相关权益政策 |
暂无数据 |
收藏/分享 |
除非特别说明,本系统中所有内容都受版权保护,并保留所有权利。
修改评论